Analysed CNS Pharmaceuticals Inc (CNSP:NASDAQ) News Sources
3 Undervalued Pharmaceuticals Stocks for Wednesday, February 25
American Association of Individual Investors
IGC Pharma, Inc.: IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
FinanzNachrichten.de
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
Yahoo Finance
ORICĀ® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Markets Insider
What is the current price of CNS Pharmaceuticals Inc (CNSP:NASDAQ)?
The current price of CNS Pharmaceuticals Inc (CNSP:NASDAQ) is $3.0.
CNS Pharmaceuticals Inc (CNSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CNS Pharmaceuticals Inc (CNSP:NASDAQ) since the previous trading day is $-0.03.
CNS Pharmaceuticals Inc (CNSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CNS Pharmaceuticals Inc (CNSP:NASDAQ) since the previous trading day is -0.99%.
What is This Week's average sentiment score for CNS Pharmaceuticals Inc (CNSP:NASDAQ)?
This Week's average sentiment score for CNS Pharmaceuticals Inc (CNSP:NASDAQ) is 77 out of 100.
What is This Week's average sentiment for CNS Pharmaceuticals Inc (CNSP:NASDAQ)?
This Week's sentiment for CNS Pharmaceuticals Inc (CNSP:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.